PACS Group, Inc.
NYSE:PACSFinancial - Conglomerates
+$0.41 today
- Market cap
- $7.35B
- Beta
- 0.00
- P/E (TTM)
- 23.0
- EPS (TTM)
- $1.55
Volume 0.78M
Average 0.84M
PACS Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
PACS Group, Inc.NYSE: PACS
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 44.1% from a year ago
Cash & equivalents stood at $164.45M at the end of Q2 FY2026, down 44.1% from a year earlier and down 33.7% from the prior quarter. Over 3 fiscal years it compounded at +50.1% a year.
Context
- Cash & equivalents amounted to 2.9% of total assets at the end of Q2 FY2026, down 2.4 pp from a year earlier.
- Cash & equivalents increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -44.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 197.02M USD
- Year-over-year change
- +25.0%
- 3-year CAGR
- +50.1%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 197.02M | +25.0% |
| FY2024 | 2024-12-31 | 157.67M | +114.8% |
| FY2023 | 2023-12-31 | 73.42M | +26.0% |
| FY2022 | 2022-12-31 | 58.27M | — |
Cash & Equivalents vs competitors
How PACS compares with its peers on the latest reported figures
- PACS's Jun 2026 cash & equivalents of $164.45M is the 7th highest of the 11 companies compared; the peer median is $216.65M.
- Its year-over-year change of -44.1% is the 10th highest of 11, against a peer median of +13.7%.
- Cash & equivalents amounts to 2.9% of total assets for PACS, versus a peer median of 5.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.01B | +7.9% | +4.6% | 1.7% | |
| Mar 2026 | $712M | +65.2% | +30.1% | 5.4% | |
| Sep 2026 | $323.37M | +27.6% | -11.2% | 5.5% | |
| Jun 2026 | $262.3M | -27.9% | +16.8% | 4.6% | |
| Jun 2026 | $225.94M | +19.6% | +31.8% | 10.4% | |
| Mar 2026 | $207.35M | +144.7% | +75.6% | 21.7% | |
| Jun 2026 | $164.45M | -44.1% | +50.1% | 2.9% | |
| Jun 2026 | $107.7M | -21.6% | +67.7% | 1.4% | |
| Mar 2026 | $95.55M | +58.0% | -29.7% | 17.5% | |
| Sep 2026 | $66.8M | -48.9% | +23.7% | 3.2% | |
| Mar 2026 | $4.91M | -5.9% | +101.6% | 0.5% | |
| Peer median (excluding PACS) | $216.65M | +13.7% | +26.9% | 5.0% | |
Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Cash & Equivalents | 58.27M | 73.42M | 157.67M | 197.02M |
| Short-term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 420.12M | 600.07M | 716.52M | 702.09M |
| Inventory | 0 | 0 | 0 | 0 |
| Other Current Assets | 32.77M | 48.67M | 64.07M | 170.63M |
| Total Current Assets | 511.16M | 722.15M | 938.26M | 1.07B |
| Property, Plant & Equipment (Net) | 1.78B | 2.59B | 3.99B | 4.17B |
| Goodwill | 55.22M | 59.02M | 60.79M | 61.79M |
| Intangible Assets | 6.27M | 6.27M | 6.27M | 6.27M |
| Long-term Investments | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 113.63M | 139.96M | 252.49M | 276.96M |
| Total Non-current Assets | 1.95B | 2.79B | 4.3B | 4.51B |
| Total Assets | 2.46B | 3.51B | 5.24B | 5.58B |
| Account Payables | 110.58M | 140.95M | 175.06M | 192.23M |
| Short-term Debt | 61.36M | 16.82M | 156.85M | 4.46M |
| Tax Payables | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 145.8M | 181.13M |
| Total Current Liabilities | 483.86M | 456.93M | 978.43M | 1B |
| Long-term Debt | 438.34M | 715.71M | 250.98M | 344.8M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 166.26M | 276.38M | 362.03M | 345.5M |
| Total Non-current Liabilities | 1.91B | 2.95B | 3.55B | 3.63B |
| Total Liabilities | 2.39B | 3.41B | 4.53B | 4.63B |
| Common Stock | 129K | 129K | 155K | 157K |
| Retained Earnings | 63.52M | 96M | 118.04M | 309.58M |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 |
| Minority Interest | 5.01M | 5.6M | 6.14M | 5.68M |
| Total Equity | 68.65M | 101.73M | 715.69M | 952.45M |
| Total Debt | 1.93B | 2.8B | 3.5B | 3.47B |
| Net Debt | 1.87B | 2.73B | 3.34B | 3.27B |
PACS Group, Inc.
NYSE:PACS
Intrinsic Alpha fair value
Locked
Current Price
$46.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.